Article

Integrating Pathology, Chromosomal Instability and Mutations for Risk Stratification in Early-stage Endometrioid Endometrial Carcinoma

2020-10-15

Abstract excerpt

<h4>Background: </h4> Risk stratifications for endometrial carcinoma (EC) depend on histopathology and molecular pathology. Histopathological risk stratification lacks reproducibility, neglects heterogeneity and contributes little to surgical procedures. Existing molecular stratification is useless in patients with specific pathological or molecular characteristics and cannot guide postoperative adjuvant radiother...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5ed255a6-2403-512a-a60e-883f5785cd9a
DOI: 10.21203/rs.3.rs-58862/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrating Pathology, Chromosomal Instability and Mutations for Risk Stratification in Early-stage Endometrioid Endometrial CarcinomaDOI 10.21203/rs.3.rs-58862/v2Read

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read

Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma.Semantic proximity Read

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancerSemantic proximity Read

New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.Semantic proximity Read

TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives.Semantic proximity Read

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.Semantic proximity Read

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsSemantic proximity Read

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read

[Thoughts on the molecular characteristics of endometrial cancer in clinical diagnosis and treatment].Semantic proximity Read

Molecular classification of endometrial carcinoma, is it the new era of precision medicine?Semantic proximity Read

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read